Successful Erlotinib Treatment for a Patient with Gefitinib-Related Hepatotoxicity and Lung Adenocarcinoma Refractory to Intermittently Administered Gefitinib

A 73-year-old Japanese man was histologically diagnosed with lung adenocarcinoma harboring an exon 19 deletion in the epidermal growth factor receptor. The patient was treated with gefitinib for 6 weeks until he developed substantially elevated hepatic enzyme levels that resulted in the discontinuat...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Tatsuya Nagano, Yoshikazu Kotani, Kazuyuki Kobayashi, Masahiro Katsurada, Yukihisa Hatakeyama, Suya Hori, Daisuke Tamura, Daisuke Kasai, Yasuhiro Funada, Yoshihiro Nishimura
Format:	Artigo
Język:	Inglês
Wydane:	Wiley 2011-01-01
Seria:	Case Reports in Pulmonology
Dostęp online:	http://dx.doi.org/10.1155/2011/812972
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!